In the last 12 months, insiders at Indivior Pharmaceuticals, Inc. ($INDV) filed 43 transactions with the SEC: 8 open-market purchases totaling $203,609 and 0 sales totaling $0. Net insider sentiment: net buying.
Indivior Pharmaceuticals, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Preblick Ryan (Chief Financial Officer) — 8 transactions totaling $2,889,798
- Heidbreder Christian (Chief Scientific Officer) — 5 transactions totaling $1,464,588
- Burris Jeffrey W (Chief Legal Officer) — 5 transactions totaling $1,152,303
- Anderson Woodrow D (Chief Accounting Officer) — 8 transactions totaling $350,661
- Wheadon David E. (Director) — 2 transactions totaling $62,680
View all SEC Filings for Indivior Pharmaceuticals, Inc. (INDV).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 14, 2026 | Preblick Ryan | Chief Financial Officer | F | Common Stock | 2843 | $31.11 | 320,751.0000 | 125,000,000 | 0.88% | 0.00% |
| March 14, 2026 | Preblick Ryan | Chief Financial Officer | M | Restricted Stock Units | 6302 | $0.00 | 0.0000 | 125,000,000 | 100.00% | 0.01% |
| March 14, 2026 | Preblick Ryan | Chief Financial Officer | M | Common Stock | 6302 | $0.00 | 323,594.0000 | 125,000,000 | 1.99% | 0.01% |
| March 13, 2026 | Ryan Barbara | Director | P | Common Stock | 8 | $31.09 | 5,724.0000 | 125,000,000 | 0.14% | 0.00% |
| March 6, 2026 | Kingsley Stuart A | Director | P | Common Stock | 940 | $31.87 | 5,582.0000 | 125,000,000 | 20.25% | 0.00% |
| March 9, 2026 | Ryan Barbara | Director | P | Common Stock | 31 | $32.56 | 5,716.0000 | 125,000,000 | 0.55% | 0.00% |
| March 3, 2026 | Preblick Ryan | Chief Financial Officer | M | Performance Stock Units | 113510 | $0.00 | 0.0000 | 125,000,000 | 100.00% | 0.09% |
| March 3, 2026 | Anderson Woodrow D | Chief Accounting Officer | M | Common Stock | 18364 | $0.00 | 29,657.0000 | 125,000,000 | 162.61% | 0.01% |
| March 3, 2026 | Anderson Woodrow D | Chief Accounting Officer | F | Common Stock | 8283 | $31.98 | 21,374.0000 | 125,000,000 | 27.93% | 0.01% |
| March 3, 2026 | Anderson Woodrow D | Chief Accounting Officer | M | Common Stock | 5946 | $0.00 | 27,320.0000 | 125,000,000 | 27.82% | 0.00% |
| March 3, 2026 | Burris Jeffrey W | Chief Legal Officer | F | Common Stock | 36032 | $31.98 | 71,518.0000 | 125,000,000 | 33.50% | 0.03% |
| March 3, 2026 | Burris Jeffrey W | Chief Legal Officer | M | Common Stock | 79893 | $0.00 | 107,550.0000 | 125,000,000 | 288.87% | 0.06% |
| March 3, 2026 | Anderson Woodrow D | Chief Accounting Officer | M | Restricted Stock Units | 5946 | $0.00 | 0.0000 | 125,000,000 | 100.00% | 0.00% |
| March 3, 2026 | Anderson Woodrow D | Chief Accounting Officer | M | Performance Stock Units | 23975 | $0.00 | 0.0000 | 125,000,000 | 100.00% | 0.02% |
| March 3, 2026 | Anderson Woodrow D | Chief Accounting Officer | F | Common Stock | 2682 | $31.98 | 24,638.0000 | 125,000,000 | 9.82% | 0.00% |
| March 3, 2026 | Heidbreder Christian | Chief Scientific Officer | M | Performance Stock Units | 132565 | $0.00 | 0.0000 | 125,000,000 | 100.00% | 0.11% |
| March 3, 2026 | Heidbreder Christian | Chief Scientific Officer | F | Common Stock | 45797 | $31.98 | 246,509.0000 | 125,000,000 | 15.67% | 0.04% |
| March 3, 2026 | Heidbreder Christian | Chief Scientific Officer | M | Common Stock | 101544 | $0.00 | 292,306.0000 | 125,000,000 | 53.23% | 0.08% |
| March 3, 2026 | Burris Jeffrey W | Chief Legal Officer | M | Performance Stock Units | 104300 | $0.00 | 0.0000 | 125,000,000 | 100.00% | 0.08% |
| March 3, 2026 | Preblick Ryan | Chief Financial Officer | F | Common Stock | 87597 | $31.98 | 230,343.0000 | 125,000,000 | 27.55% | 0.07% |
| March 3, 2026 | Preblick Ryan | Chief Financial Officer | M | Common Stock | 86949 | $0.00 | 317,292.0000 | 125,000,000 | 37.75% | 0.07% |
| Feb. 10, 2026 | Heidbreder Christian | Chief Scientific Officer | A | Common Stock | 33622 | $0.00 | 190,762.0000 | 125,000,000 | 21.40% | 0.03% |
| Feb. 10, 2026 | Preblick Ryan | Chief Financial Officer | A | Common Stock | 37358 | $0.00 | 317,940.0000 | 125,000,000 | 13.31% | 0.03% |
| Feb. 9, 2026 | Preblick Ryan | Chief Financial Officer | A | Performance Stock Units | 113510 | $0.00 | 113,510.0000 | 125,000,000 | 9999.99% | 0.09% |
| Feb. 10, 2026 | Anderson Woodrow D | Chief Accounting Officer | A | Common Stock | 6903 | $0.00 | 11,293.0000 | 125,000,000 | 157.24% | 0.01% |
| Feb. 9, 2026 | Anderson Woodrow D | Chief Accounting Officer | A | Performance Stock Units | 23975 | $0.00 | 23,975.0000 | 125,000,000 | 9999.99% | 0.02% |
| Feb. 10, 2026 | Burris Jeffrey W | Chief Legal Officer | A | Common Stock | 26897 | $0.00 | 27,657.0000 | 125,000,000 | 3539.08% | 0.02% |
| Feb. 9, 2026 | Burris Jeffrey W | Chief Legal Officer | A | Performance Stock Units | 104300 | $0.00 | 104,300.0000 | 125,000,000 | 9999.99% | 0.08% |
| Feb. 9, 2026 | Heidbreder Christian | Chief Scientific Officer | A | Performance Stock Units | 132565 | $0.00 | 132,565.0000 | 125,000,000 | 9999.99% | 0.11% |
| Feb. 10, 2026 | Barry Patrick A | Chief Commercial Officer | A | Common Stock | 31380 | $0.00 | 31,380.0000 | 125,000,000 | 9999.99% | 0.03% |
| Feb. 10, 2026 | Ciaffoni Joseph | Chief Executive Officer | A | Common Stock | 79976 | $0.00 | 135,976.0000 | 125,000,000 | 142.81% | 0.06% |
| Jan. 26, 2026 | Kingsley Stuart A | Director | A | Common Stock | 3722 | $0.00 | 4,642.0000 | 125,000,000 | 404.57% | 0.00% |
| Jan. 26, 2026 | Humphreys Keith | Director | A | Common Stock | 3722 | $0.00 | 9,524.0000 | 125,000,000 | 64.15% | 0.00% |
| Jan. 26, 2026 | Thompson Juliet | Director | A | Common Stock | 3722 | $0.00 | 13,347.0000 | 125,000,000 | 38.67% | 0.00% |
| Jan. 26, 2026 | Stejbach Mark | Director | A | Common Stock | 3722 | $0.00 | 20,569.0000 | 125,000,000 | 22.09% | 0.00% |
| Jan. 26, 2026 | NINIVAGGI DANIEL A | Director | A | Common Stock | 3722 | $0.00 | 20,645.0000 | 125,000,000 | 21.99% | 0.00% |
| Jan. 26, 2026 | Ryan Barbara | Director | A | Common Stock | 3722 | $0.00 | 5,685.0000 | 125,000,000 | 189.61% | 0.00% |
| Jan. 26, 2026 | Wheadon David E. | Director | A | Common Stock | 5955 | $0.00 | 20,350.0000 | 125,000,000 | 41.37% | 0.00% |
| Jan. 5, 2026 | Wheadon David E. | Director | P | Ordinary Shares | 1771 | $35.39 | 14,395.0000 | 125,000,000 | 14.03% | 0.00% |
| Jan. 5, 2026 | Stejbach Mark | Director | P | Ordinary Shares | 775 | $35.39 | 16,847.0000 | 125,000,000 | 4.82% | 0.00% |
| Jan. 5, 2026 | NINIVAGGI DANIEL A | Director | P | Ordinary Shares | 775 | $35.39 | 16,923.0000 | 125,000,000 | 4.80% | 0.00% |
| Jan. 5, 2026 | Humphreys Keith | Director | P | Ordinary Shares | 775 | $35.39 | 5,802.0000 | 125,000,000 | 15.42% | 0.00% |
| Jan. 5, 2026 | Ryan Barbara | Director | P | Ordinary Shares | 775 | $35.39 | 1,963.0000 | 125,000,000 | 65.24% | 0.00% |